KLRG1 and inclusion body myositis: Furthermore, in IBM patients, CD8+ T cells display increased expression of the killer-cell lectin-like receptor-1 (KLRG1), an inhibitory receptor that, upon engagement by its ligands E and N cadherins, negatively impacts cell proliferation (3).